Buprenorphine transdermal skin patch and Cisatracurium Besylate
Determining the interaction of Buprenorphine transdermal skin patch and Cisatracurium Besylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: cisatracurium
Brand name: Nimbex
Synonyms: Cisatracurium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Cisatracurium Besylate Injection
- Buprenorphine transdermal skin patch-Cisatracurium besylate Intravenous
- Buprenorphine transdermal skin patch-Cisplatin
- Buprenorphine transdermal skin patch-Cisplatin Intravenous
- Buprenorphine transdermal skin patch-Citalopram
- Buprenorphine transdermal skin patch-Citalopram Capsules
- Cisatracurium Besylate-Buprenorphine, Buprenorphine Hydrochloride
- Cisatracurium Besylate-Buprenorphine/naloxone Oromucosal, Sublingual
- Cisatracurium Besylate-Buproban
- Cisatracurium Besylate-Bupropion
- Cisatracurium Besylate-Bupropion and naltrexone
- Cisatracurium Besylate-Bupropion Extended-Release Tablets